Guardant Health Future Growth

How is Guardant Health forecast to perform in the next 1 to 3 years based on estimates from 17 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


20.2%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGS:GH - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2024727-467-379-32213
12/31/2023564-537-482-42517
12/31/2022445-640-371-28517
9/30/2022431-606-388-296N/A
6/30/2022408-551-363-271N/A
3/31/2022391-419-309-221N/A
12/31/2021374-406-284-209N/A
9/30/2021344-409-249-191N/A
6/30/2021324-379-191-146N/A
3/31/2021298-336-143-107N/A
12/31/2020287-254-158-104N/A
9/30/2020271-185-129-75N/A
6/30/2020258-120-118-66N/A
3/31/2020245-77-102-56N/A
12/31/2019214-76-68-47N/A
9/30/2019184-76-60-43N/A
6/30/2019145-87-81-67N/A
3/31/2019111-97-89-70N/A
12/31/201891-85-92-72N/A
9/30/201878-75-85-64N/A
6/30/201867-84-87-68N/A
3/31/201857-83-77-65N/A
12/31/201750-89-81-72N/A
12/31/201625-46-38-37N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: GH is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: GH is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: GH is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: GH's revenue (23.3% per year) is forecast to grow faster than the US market (6.9% per year).

High Growth Revenue: GH's revenue (23.3% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if GH's Return on Equity is forecast to be high in 3 years time


Discover growth companies